최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of the Chosun Natural Science = 조선자연과학논문집, v.11 no.2, 2018년, pp.93 - 100
Sathya., B (Department of Genetic Engineering, School of Bioengineering, SRM Institute of Science and Technology)
Caspases, a family of cysteinyl aspartate-specific proteases plays a central role in the regulation and the execution of apoptotic cell death. Caspase-3 has been proven to be an effective target for reducing the amount of cellular and tissue damage because the activation of caspases-3 stimulates a s...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
M. D. Jacobson, M. Weil, and M. C Raff, "Pro-grammed cell death in animal development", Cell, Vol. 88, pp. 347-354, 1997.
G. M. Cohen, "Caspases: the executioners of apoptosis", Biochem. J., Vol. 326, pp. 1-16, 1997.
C. B. Thonberry and Y. Lazebnik, "Caspases: enemied within", Science, Vol. 281, pp. 1312-1316, 1998.
D. W. Nicolson, "Caspase structure, proteolytic substrates, and function during apoptotic cell death", Cell Death Differ., Vol. 6, pp. 1028-1042, 1999.
J. Wang, M. J. Lenardo, "Roles of caspases in apoptosis, development and cytokine maturation revealed by homozygous gene deficiencies", J. Cell Sci., Vol. 113, pp. 753-757, 2000.
M. Endres, S. Namura, M. Shomizu-Sasamata. C. Waeber, L. Zhang, T. Gomez-Isla, B. T. Hyman, and M. A. Moskowitz, "Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of caspase family", J. Cereb. Blood Flow Metab., Vol. 18, pp. 238-247, 1998.
K. M. Boatright and G. S. Salvesen, "Mechanisms of caspase activation", Curr. Opin. Cell Biol., Vol. 15, pp. 725-731, 2003.
B. A. Callus and D. L. Vaux, "Caspase inhibitors: viral, cellular and chemical", Cell Death Differ., Vol. 14, pp. 73-78, 2007.
B. H. Han, D. Xu, J. Cho, Y. Han, S. Xanthoudakis, S. Roy, J. Tam, J. Vaillancourt, J. Colucci, R. Siman, A. Giroux, G. S. Robertson, R. Zamboni, D. W. Nicholson, and D. M. Holtzman, "Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury", J. Biol. Chem., Vol. 277, pp. 30128-30136, 2002.
R. S. Hotchkiss, K. C. Chang , P. E. Swanson, K. W. Tinsley, J. J. Hui, P. Klender, S. Xanthoudakis, S. Roy, C. Black, E. Grimm, R. Aspiotis, Y. Han, D. W. Nicholson, and I. E. Karl, "Caspase inhibitors improves survival in sepsis: a critical role of the lymphocyte", Nat. Immunol., Vol. 1, pp. 496-501, 2000.
D. Lee, S. A. Long, J. H. Murray, J. L. Adams, M. E. Nuttall, D. P. Nadeau, K. Kikly, J. D. Winkler, C.-M. Sung, M. D. Ryan, M. A. Levy, P. M. Keller, and W. E. DeWolf, "Potent and selective non pep- tide inhibitors of caspase 3 and 7", J. Med. Chem., Vol. 44, pp. 2015-2026, 2001.
H. Yaoita, K. Ogawa, K. Maehara, and Y. Maruyama, "Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor", Circulation, Vol. 97, pp. 276-281, 1998.
J. Schoenberger, J. Bauer, J. Moosbauer, C. Eilles, and D. Grimm, "Innovative strategies in in-vivo apoptosis imaging", Curr. Med. Chem., Vol. 15, pp. 187-194, 2008.
D. K. Perry, M. J. Smyth, H. R. Stennicke, G. S. Salvessan, P. Duriez, G. G. Poirier, and Y. A. Han- nun, "Zinc is a potent inhibitor of the apoptotic protease, caspase-3. a novel target for zinc in the inhibition of apoptosis", J. Biol. Chem., Vol. 272, pp. 18530-18533, 1997.
A. G. Porter and R. U. Janicke, "Emerging roles of caspase 3 in apoptosis", Cell Death Differ., Vol. 6, pp. 99-104, 1999.
C. W. Scott, C. Sobotka-Brinker, D. E. Wilkins, R. T. Jacobs, J. J. Folmer, W. J. Frazee, R. V. Bhat, S. V. Ghanekar, and D. Aharony, "Novel small molecule inhibitors of caspase-3 block cellular and bio-chemical features of apoptosis", J. Pharmacol. Exp. Ther., Vol. 304, pp. 433-440, 2003.
D. V. Kravchenko, V. M. Kysil, S. E. Tkachenko, S. Maliarchouk, I. M. Okun, and A. V. Ivanchtch- enko, "Pyrrolo[3,4-c]quinoline-1,3-diones as potent caspase-3 inhibitors. Synthesis and SAR of 2-sub- stituted 4-methyl-8-(morpholine-4-sulfonyl)-pyrrolo [3,4-c]quinoline-1,3-diones", Eur. J. Med. Chem., Vol. 40, pp. 1377-1383, 2005.
W. Chu, J. Zhang, C. Zeng, J. Rothfuss, Z. Tu, Y. Chu, D. E. Reichert, M. J. Welch, and R. H. Mach, "N-Benzylisatin sulfonamide analogues as potent caspase-3 inhibitors: Synthesis, in vitro activity and molecular modeling studies", J. Med. Chem., Vol. 48, pp. 7637-7647, 2005.
L. M. Havran, D. C. Chong, W. E. Childers, P. J. Dollings, A. Dietrich, B. L. Harrison, V. Marathias, G. Tawa, A. Aulabaugh, R. Cowling, B. Kapoor, W. Xu, L. Mosyak, F. Moy, W.-T. Hum, A. Wood, and A. J. Robichaud, "3.4-Dihydropyrimido (1,2-a indol-10(2H)-ones as potent non-peptidic inhibitors of caspase-3", Bioorg. Med. Chem., Vol. 17, pp. 7755-7768, 2009.
Tripos Sybyl, HQSAR manual.
C. L. Waller, "A comparative QSAR study using CoMFA, HQSAR, and FRED/SKEYS paradigms for estrogen receptor binding affinities of structur- ally diverse compounds", J. Chem. Inf. Comput. Sci., Vol. 44, pp. 758-765, 2004.
W. Tong, D. R. Lowis, R. Perkins, Y. Chen, W. J. Welsh, D. W. Goddette, T. W. Heritage, and D. M. Sheehan, "Evaluation of quantitative structure-activity relationship methods for large-scale prediction of chemicals binding to the estrogen receptor", J. Chem. Inf. Comput. Sci., Vol. 38, pp. 669-677, 1998.
M. Thirumurthy, K. Gugan, C. G. Gadhe, and J. C. Segung, "QSAR analysis on PfPK7 inhibitors using HQSAR, CoMFA and CoMSIA", Med. Chem. Res., Vol. 21, pp. 681-693, 2012.
T. W Heritage and D. R. Lowis, "Molecular Holo-gram QSAR", In Rational Drug Design, Washing-ton: American Chemical Society, ACS Symposium Series, Vol. 719, pp 212-225, 2000.
S. Wold, "Cross-validatory estimation of the num- ber of components in factor and principal component model", Technometrics, Vol. 20, pp. 397-405, 1978.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Free Access. 출판사/학술단체 등이 허락한 무료 공개 사이트를 통해 자유로운 이용이 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.